Preferred Name |
Linezolid |
|
Synonyms |
LINEZOLID Linezolid Zyvox |
|
Definitions |
A synthetic oxazolidinone derivative, Linezolid selectively inhibits an early step in bacterial protein synthesis and affects blood pressure through monoamine oxidase inhibition. It is effective against Gram-positive organisms, including methicillin-resistant Staphylococcus aureus strains, coagulase-negative Staphylococci, vancomycin-resistant Enterococci, and penicillin-resistant Streptococcus pneumoniae strains. (NCI04) |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29158 |
|
CAS_Registry |
165800-03-3 |
|
CHEBI_ID |
CHEBI:63607 |
|
Chemical_Formula |
C16H20FN3O4 |
|
code |
C29158 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
Contributing_Source |
CTRP FDA |
|
DEFINITION |
A synthetic oxazolidinone derivative, Linezolid selectively inhibits an early step in bacterial protein synthesis and affects blood pressure through monoamine oxidase inhibition. It is effective against Gram-positive organisms, including methicillin-resistant Staphylococcus aureus strains, coagulase-negative Staphylococci, vancomycin-resistant Enterococci, and penicillin-resistant Streptococcus pneumoniae strains. (NCI04) |
|
Display_Name |
Linezolid |
|
FDA_UNII_Code |
ISQ9I6J12J |
|
FULL_SYN |
LINEZOLID Linezolid Zyvox |
|
label |
Linezolid |
|
Legacy Concept Name |
Linezolid |
|
NCI_Drug_Dictionary_ID |
735710 |
|
PDQ_Closed_Trial_Search_ID |
735710 |
|
PDQ_Open_Trial_Search_ID |
735710 |
|
Preferred_Name |
Linezolid |
|
prefixIRI |
Thesaurus:C29158 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance Antibiotic |
|
UMLS_CUI |
C0663241 |
|
subClassOf |